| 英文别名 |
Oxypeucedanin hydrate;7H-Furo[3,2-g][1]benzopyran-7-one,4-(2,3-dihydroxy-3-methylbutoxy)-,(R)-;7H-Furo[3,2-g][1]benzopyran-7-one,4-[(2R)-2,3-dihydroxy-3-methylbutoxy]-;OXYPEUCEDANIN HYDRATE(P);Oxypeucedaninhydrate;Prangolarin hydrate;(+)-Oxypeucedanin hydrate;Prawgol;Hydroxypeucedanin hydrate;(R)-oxypeucedanin hydrate;7H-Furo(3,2-g)(1)benzopyran-7-one, 4-(2,3-dihydroxy-3-methylbutoxy)-, (R)-;7H-FURO(3,2-g)(1)BENZOPYRAN-7-ONE, 4-(2,3-DIHYDROXY-3-METHYLBUTOXY)-, (R)-(+)-;Aviprin;MLS000574909;Aviprin (Oxypeucedaninhydrate);HMS2196F22;BDBM50361377;SMR000156244;1ST164211;CHEBI:69829;AKOS000278024;4-[(2R)-2,3-dihydroxy-3-methyl-butoxy]furo[3,2-g]chromen-7-one;2643-85-8;NS00094521;MS-24390;(+)-Oxypeucedaninhydrate;CHEMBL454060;HY-N2622;DTXSID90949318;7H-Furo[3,2-g][1]benzopyran-7-one, 4-[(2R)-2,3-dihydroxy-3-methylbutoxy]-;4-[(2R)-2,3-dihydroxy-3-methylbutoxy]furo[3,2-g]chromen-7-one;Q27138170;CS-0023028;Prangol;(R)-(+)-Oxypeucedanin Hydrate;Dihydroxypeucedanin;ConMedNP.1785;ConMedNP.1784;SMR000440613;MLSMR;MLS000877013;(+)-Aviprin;DA-56521 |